Targeting TIGIT to alleviate costimulation blockade-resistant rejection: Analysis of the effects of TIGIT agonism on regulatory and memory T cells during allograft rejection
1 of 2
Imatinib mesylate as a host directed therapeutic for mycobacterial infection